Stereoselective synthesis of (S)-3-(methylamino)-3-((R)-pyrrolidin-3-yl)propanenitrile |
| |
Authors: | Lall Manjinder S Hoge Garrett Tran Tuan P Kissel William Murphy Sean T Taylor Clarke Hutchings Kim Samas Brian Ellsworth Edmund L Curran Timothy Showalter H D Hollis |
| |
Affiliation: | Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States. manjinder.lall@pfizer.com |
| |
Abstract: | (S)-3-(methylamino)-3-((R)-pyrrolidin-3-yl)propanenitrile (1) is a key intermediate in the preparation of PF-00951966, (1) a fluoroquinolone antibiotic for use against key pathogens causing community-acquired respiratory tract infections including multidrug resistant (MDR) organisms. The current work describes the development of a highly efficient and stereoselective synthesis of 1 in 10 steps with an overall yield of 24% from readily available benzyloxyacetyl chloride. Two key transformations in the synthetic sequence involve (a) catalytic asymmetric hydrogenation with chiral DM-SEGPHOS-Ru(II) complex to afford β-hydroxy amide 11b in good yield (73%) and high stereoselectivity (de 98%, ee >99%) after recrystallization and (b) S(N)2 substitution reaction with methylamine to provide diamine 14 with inversion of configuration at the 1'-position in high yield (80%), after efficient purification using a simple acid/base extraction protocol. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|